HELIO

HELIO

商务咨询服务

Morristown,NJ 1,100 位关注者

We Live Life Sciences.

关于我们

HELIO is a tech-enabled, professional services company dedicated to Life Sciences. We offer unrivaled Compliance and Commercial expertise through Consulting, Technology-Enabled Services, and AI Solutions. Our all-consuming passion has helped our life sciences clients achieve transformative success in this critical industry...and beyond. We Live Life Sciences.

网站
https://www.heliohealthgroup.com
所属行业
商务咨询服务
规模
11-50 人
总部
Morristown,NJ
类型
私人持股
创立
2015

地点

  • 主要

    89 Headquarters Plaza North

    #1443

    US,NJ,Morristown,07960

    获取路线

HELIO员工

动态

  • HELIO转发了

    查看Steven Moore的档案,图片

    Chief Commercial Officer at HELIO

    Fantastic article by HELIO’s Chris Cobourn. If you’re an emerging life sciences company that needs guidance on your launch and Govermment Programs participation, operational requirements and implications - HELIO is here to help!

    查看HELIO的公司主页,图片

    1,100 位关注者

    We are getting closer and closer to the Informa Connect MDRP Summit that runs September 23rd to 25th in Chicago! With that in mind, we wanted to continue our Government Programs (GP) posting with a new white paper written by our very own Chris Cobourn on "GP Participation for Emerging Pharma & Biotech." A reminder that Chris will be speaking alongside William Sarraille and Marijo Bustos on September 25th (https://lnkd.in/exgbqVnz) The HELIO team specializes in GP, Transparency and all Compliance considerations for companies of every size, including and especially those launching their very first product. This insightful read will give you a sense of our ability to deftly steer and advise your company through this critical timeframe. Please reach out to Steven Moore at [email protected] - even if for just a conversation on how we can help. Finally - HELIO has one more surprise announcement coming ahead of the MDRP conference next week... Stay tuned!!! ;-)

  • HELIO转发了

    查看HELIO的公司主页,图片

    1,100 位关注者

    CMS Open Payments Audits have started - and HELIO is here to help! HELIO collects, compiles and submits Transparency reports for a multitude of life sciences companies annually. And while HELIO has continued to create, assess and implement reporting entities' Transparency programs well before the CMS audits began, we are now also helping companies focus on their CMS audit readiness. Additionally, HELIO has made this offering more unique by using our secure AI technology to review large data sets during transactional related Compliance audits.? See the included information sheet for more details on how HELIO can help. Please reach out to Steven Moore at [email protected] for more information on how we can help your company proactively prepare.

  • HELIO转发了

    查看HELIO的公司主页,图片

    1,100 位关注者

    We are getting closer and closer to the Informa Connect MDRP Summit that runs September 23rd to 25th in Chicago! With that in mind, we wanted to continue our Government Programs (GP) posting with a new white paper written by our very own Chris Cobourn on "GP Participation for Emerging Pharma & Biotech." A reminder that Chris will be speaking alongside William Sarraille and Marijo Bustos on September 25th (https://lnkd.in/exgbqVnz) The HELIO team specializes in GP, Transparency and all Compliance considerations for companies of every size, including and especially those launching their very first product. This insightful read will give you a sense of our ability to deftly steer and advise your company through this critical timeframe. Please reach out to Steven Moore at [email protected] - even if for just a conversation on how we can help. Finally - HELIO has one more surprise announcement coming ahead of the MDRP conference next week... Stay tuned!!! ;-)

  • 查看HELIO的公司主页,图片

    1,100 位关注者

    HELIO is extremely excited to welcome Mark Sabatelli to the team as its Executive Director, Business Development.?Mark brings a tremendous amount of Government Pricing and Compliance experience to the team and rejoins colleagues Steven Moore and Chris Cobourn - who he helped build Compliance Implementation Service (CIS) prior to its acquisition by Deloitte. Swing by our booth at the MDRP Conference today through Wednesday to learn more!

    查看Mark Sabatelli的档案,图片

    Executive Director Business Development at Helio Health Group

    I’m happy to share that I’m starting a new position as Executive Director Business Development at HELIO Health Group!

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看HELIO的公司主页,图片

    1,100 位关注者

    We are getting closer and closer to the Informa Connect MDRP Summit that runs September 23rd to 25th in Chicago! With that in mind, we wanted to continue our Government Programs (GP) posting with a new white paper written by our very own Chris Cobourn on "GP Participation for Emerging Pharma & Biotech." A reminder that Chris will be speaking alongside William Sarraille and Marijo Bustos on September 25th (https://lnkd.in/exgbqVnz) The HELIO team specializes in GP, Transparency and all Compliance considerations for companies of every size, including and especially those launching their very first product. This insightful read will give you a sense of our ability to deftly steer and advise your company through this critical timeframe. Please reach out to Steven Moore at [email protected] - even if for just a conversation on how we can help. Finally - HELIO has one more surprise announcement coming ahead of the MDRP conference next week... Stay tuned!!! ;-)

  • 查看HELIO的公司主页,图片

    1,100 位关注者

    HELIO Webinar Re-Post: "25 Years in the GP Trenches" HELIO is super excited that the Informa MDRP Conference is only a week away from today!?Chris Cobourn and Steven Moore look forward to connecting with so many long-time industry friends and making new connections. We also encourage those attending to join our session at 10:50AM on September 25th, where Chris, William Sarraille and Marijo Bustos where they will discuss navigating the complexities of recalculations (https://lnkd.in/exgbqVnz). In anticipation of the conference, we wanted to re-post our Government Pricing webinar, “25 Years in the GP Trenches” featuring HELIO’s own Chris and Joseph Skupen CPA, and moderated by Marci Juneau. Please click this link: https://lnkd.in/es_RV9mH to learn more about our GP services and watch the informative webinar. See you next week! The HELIO Team As always, feel free to reach out to Steven Moore at [email protected] for more information on how we can help you with your Government Pricing, Transparency and overall Compliance needs - especially how HELIO is harnessing the power of AI in its tools and services! #HELIO #GovernmentPricing #MDRP #GP #Recalculation #GPGeek

    HELIO

    HELIO

    heliogrp.com

  • 查看HELIO的公司主页,图片

    1,100 位关注者

    Great article and additional insights by John Poulin!

    查看John Poulin的档案,图片

    Chief Technology Officer and Partner at Helio Health Group

    Great article from an insightful group of compliance professionals. Many of whom we have collaborated with and have great respect for. This piece dives deep into the critical role of Patient Advocacy Organizations (PAOs) in rare disease research and development. It highlights how these organizations are not just a bridge between patients and the pharmaceutical industry but are also pivotal in driving the development of new treatments. The discussion around the regulatory challenges and the need for more comprehensive patient support services, such as concierge services, is particularly relevant for anyone involved in clinical trials or rare disease advocacy. The article also sheds light on the complexities of conducting rare disease clinical trials, especially when patient populations are globally dispersed. The emphasis on patient-centered approaches and the collaboration between PAOs and the industry is a powerful reminder of how important it is to keep the patient experience at the heart of drug development. Kudos to the authors for bringing these critical issues to the forefront. You can read the full article: https://lnkd.in/eSbfXsgg Michele Girdharry Donna White Sarah Whipple Chad Morin Gary F. Giampetruzzi Patrik Florencio

    Considerations in View of the Lived Experience of Affected Individuals: Compliance in the Rare Disease Space?

    Considerations in View of the Lived Experience of Affected Individuals: Compliance in the Rare Disease Space?

    https://www.healthcarebusinesstoday.com

  • 查看HELIO的公司主页,图片

    1,100 位关注者

    Mergers and acquisitions (M&A) continue to be a primary driver of growth in the life sciences industry. The forces and economic pressures created by the Inflation Reduction Act's price “negotiation” and Prescription Drug Affordability Boards has only intensified the importance of M&A in the industry.?A key challenge we have seen is the potential unforeseen Government Programs (GP)?impacts from M&A activity.?It is important for those involved in the deal's due diligence to be informed of the potential GP impacts and make informed decisions throughout the entire process.?In this paper William Sarraille and HELIO's own Chris Cobourn discuss GP due diligence within deal making in the industry, as well as how to avoid the risks and pitfalls that can result in significant compliance and financial issues that can be extremely difficult to mitigate post-deal. Also note that Bill, Chris and UCB's Marijo Bustos will be speaking together at the MDRP Conference in Chicago, which takes place September 23-25 (https://lnkd.in/ehWaWNfV). Stop by our booth to say hello and learn more about how HELIO can help you with all of your Government Pricing and Compliance needs! Please email Steven Moore at [email protected] for a discussion on this paper tailored to your company and situation, or for any other potential ways HELIO can help. #HELIO #M&A #LifeSciences #GovernmentPricing #GovernmentPrograms #MDRP #Compliance

  • 查看HELIO的公司主页,图片

    1,100 位关注者

    CMS Open Payments Audits have started - and HELIO is here to help! HELIO collects, compiles and submits Transparency reports for a multitude of life sciences companies annually. And while HELIO has continued to create, assess and implement reporting entities' Transparency programs well before the CMS audits began, we are now also helping companies focus on their CMS audit readiness. Additionally, HELIO has made this offering more unique by using our secure AI technology to review large data sets during transactional related Compliance audits.? See the included information sheet for more details on how HELIO can help. Please reach out to Steven Moore at [email protected] for more information on how we can help your company proactively prepare.

相似主页

查看职位